galiximab
volociximab
amatuximab
rituximab
ibritumomab tiuxetan
lumiliximab
lymphomonocytic
loncastuximab tesirine
bavituximab
clenoliximab
tabalumab
tositumomab
vapaliximab
ensituximab
mogamulizumab
edrecolomab
lysocyte
mosunetuzumab
achroacytosis
antiplasma
cytophilic antibody
cytotropic antibody
anaphylactic antibody
Waldenström's macroglobulinemia
talizumab
veltuzumab
immunocytoma
intralymphocytic
lymphologically
-les-
lymphocytotic
atezolizumab
memory cell
lymphological
monoantibody
afutuzumab
lymphoplasmocytic
humoral immunity
-mab
hematogone
tenatumomab
hybridoma
muromonab
intrabody
antilymphocyte
cergutuzumab
chromobody
immunoblastoma
alemtuzumab
antimonoclonal